Morphosys Ag's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 30.07, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2023. Average receivable collection period, for the Morphosys Ag in Dec 31 2023 quarter, has decreased to 12 days, compared to 29 days, in the 0 quarter.

If we take a look into Healthcare sector 501 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 2353 to 3482.

What is Receivable Turnover Ratio?
What is Morphosys Ag Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MOR Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	-63.62 %	-	-	-	13.6 %
Y / Y Revenue Change	-14.37 %	-	-	-	54.93 %
Receivable Turnover Ratio (TTM)	30.07	12.77	12.77	12.77	12.77
MOR's Total Ranking	# 3482	# 2353	# 3403	# 0	# 2962
Accounts Receivable average collection period days	12	29	29	29	29
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 184
Healthcare Sector	# 502
Overall Market	# 3482

Receivable Turnover Ratio Statistics
High	Average	Low
0.2	0.13	0.07
(Dec 31 2020)		(Dec 31 2021)

MOR Company Profile • Back to MOR Efficiency Comparisons • Compare MOR Receivables Turnover Ratio to its Competitors

Financial Statements
Morphosys Ag's Accounts Receivable	$ 36 Millions	Visit MOR's Balance sheet
Morphosys Ag's Sales TTM	$ 267 Millions	Visit MOR's Income Statement
Sources of MOR's Revenues		Visit MOR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MOR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MOR's Growth Rates	MOR's Roa	MOR's Inventory Turnover Ratio	MOR's Dividend Comparisons
MOR's Profitability Ratios	MOR's Roi	MOR's Asset Turnover Ratio	MOR's Dividend Growth
MOR's Valuation Ratios	MOR's Roe	MOR's Financial Strength Ratios	MOR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Editas Medicine Inc	20.64	$ 78.123 Millions	$ 3.784 Millions
Cue Health Inc	20.01	$ 70.936 Millions	$ 3.545 Millions
Arvinas Inc	19.87	$ 78.500 Millions	$ 3.950 Millions
Rosecliff Acquisition Corp I	19.74	$ 18.056 Millions	$ 0.915 Millions
Kiniksa Pharmaceuticals International Plc	19.17	$ 270.259 Millions	$ 14.095 Millions
American Oncology Network Inc	18.94	$ 1,279.185 Millions	$ 67.548 Millions
U S Physical Therapy Inc	18.56	$ 487.150 Millions	$ 26.251 Millions
Marizyme Inc	18.31	$ 0.646 Millions	$ 0.035 Millions
Bespoke Extracts Inc	17.46	$ 0.786 Millions	$ 0.045 Millions
Halozyme Therapeutics Inc	17.02	$ 829.253 Millions	$ 48.721 Millions
Qhslab Inc	16.93	$ 1.409 Millions	$ 0.083 Millions
Lftd Partners Inc	16.56	$ 51.611 Millions	$ 3.117 Millions
Wave Life Sciences Ltd	16.14	$ 113.305 Millions	$ 7.022 Millions
Neuraxis Inc	15.95	$ 2.460 Millions	$ 0.154 Millions
Talkspace Inc	15.31	$ 149.380 Millions	$ 9.757 Millions
Xortx Therapeutics inc	15.15	$ 0.919 Millions	$ 0.061 Millions
Milestone Scientific Inc	15.03	$ 9.793 Millions	$ 0.651 Millions
Chemed Corporation	14.52	$ 2,264.417 Millions	$ 155.918 Millions
Icu Medical Inc	14.46	$ 2,259.126 Millions	$ 156.262 Millions
Patterson Companies Inc	14.11	$ 6,565.239 Millions	$ 465.318 Millions
Utah Medical Products Inc	14.01	$ 50.097 Millions	$ 3.575 Millions
Escalon Medical Corp	13.89	$ 12.384 Millions	$ 0.892 Millions
Tvardi Therapeutics Inc	13.71	$ 20.968 Millions	$ 1.529 Millions
Corcept Therapeutics Inc	13.70	$ 482.375 Millions	$ 35.215 Millions
Addex Therapeutics Ltd	13.68	$ 1.796 Millions	$ 0.131 Millions
Theralink Technologies Inc	13.67	$ 0.511 Millions	$ 0.037 Millions
Precipio inc	13.43	$ 15.197 Millions	$ 1.132 Millions
Protalix Biotherapeutics inc	13.39	$ 65.494 Millions	$ 4.890 Millions
Lifeloc Technologies Inc	13.20	$ 9.330 Millions	$ 0.707 Millions
Exact Sciences Corporation	13.11	$ 2,507.149 Millions	$ 191.178 Millions

Date modified: 2026-10-07T00:41:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.